Skip to main content
Have a personal or library account? Click to login
Human Leukocyte Antigen-B27 and Disease Susceptibility in Vojvodina, Serbia Cover

Human Leukocyte Antigen-B27 and Disease Susceptibility in Vojvodina, Serbia

Balkan Journal of Medical Genetics
Volume 15 (2012): Issue 2 (December 2012)
By: ,   and    
Open Access
|Apr 2013
References

References

  1. 1. Hulsmeyer M, Hillig RC, Volz A, Ruhl M, Schroder W, Saengen W,HLA-B27 Subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem. 2002; 227(49): 47844-47853.
    Open DOISearch in Google Scholar
  2. 2. Popa OM, Bojinica M, Bojinica V, Ciofu C, Dutescu MI, Bardan A,Distribution of HLAB27 in Romanian spondyloarthritides patients. Int J Immunogenet. 2010; 37(6): 513-516.
    Open DOISearch in Google Scholar
  3. 3. Colbert RA, DeLay ML, Layh-Schmitt G, Sowders DP. HLA-B27 misfolding and spondyloarthropathies. Prion. 2009; 3(1): 15-26.
    Open DOISearch in Google Scholar
  4. 4. Bowness P. HLA B27 in health and disease: a double-edged sword? Rheumatology. 2002; 41(8): 857-868.
    Open DOISearch in Google Scholar
  5. 5. Huhtinen M. Acute anterior uveitis and HLAB27: infectious background, systemic inflamation and prognosis of the patients. Academic dissertation, defended at the Medical Faculty of the University of Helsinki, Helsinki, 2002.
    Search in Google Scholar
  6. 6. Allen RL, Bowness P, McMichael AJ. The role ofin spondyloarthritis. Immunogenetics. 1999; 50(3-4): 220-227.
    Open DOISearch in Google Scholar
  7. 7. Marsh SGE. Nomenclature for factors of the HLA system, update September 2011. Int J Immunogenet. 2011; 39(1): 95-97.
    Open DOISearch in Google Scholar
  8. 8. Khan MA. Recent advances in the genetics of ankylosing spondylitis. Future Rheumatol. 2008; 3(5): 403-405.
    Open DOISearch in Google Scholar
  9. 9. Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, Bitti P,Increased level of HLA B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology. 2002; 41(12): 1375-1379.
    Open DOISearch in Google Scholar
  10. 10. Vartdal F, Gaudernack G, Funderud S, Bratlie A, Lea T, Ugelstad J,HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation-a fast and reliable technique. Tissue Antigens. 1986; 25(5): 301-312.
    Open DOISearch in Google Scholar
  11. 11. Vartdal F, Bratlie A, Gaudernack G, Funderud S, Lea T, Thorsby E. Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres. Transplant Proceedings. 1987; 19(1): 655-657.
    Search in Google Scholar
  12. 12. Walker RH. Technical Manual, 11th ed. Bethesda: American Association of Blood Banks, 1993: 305-307.
    Search in Google Scholar
  13. 13. Stites DP, Stobo JD, Wells JV. Osnovna i klinička imunologija. Beograd: Savremena Administracija, 1989; 50-63.
    Search in Google Scholar
  14. 14. Svejgaard A, Platz R, Ryder LP. HLA and disease 1982-A survey. Immunolog Rev. 1983; 70(1): 193-201.
    Open DOISearch in Google Scholar
  15. 15. Bengston BO, Thompson G. Measuring the strength of associations between HLA antigens and disease. Tissue Antigens. 1981; 18(5): 356-363.
    Open DOISearch in Google Scholar
  16. 16. Green A. The epidemiologic approach to studies of association between HLA and disease.II Estimation of absolute risk, etiologic and preventive fraction. Tissue Antigens. 1982; 19(4): 259-168.
    Open DOISearch in Google Scholar
  17. 17. Petz B. Osnovne statističke metode. Zagreb: Izdanja škole narodnog zdravlja “Andrija Štampar.” 1967: 111-134.
    Search in Google Scholar
  18. 18. Snedecor GW, Cochan GW. Statistical Methods. Ames: The Iowa State University Press. 1956: 219-221.
    Search in Google Scholar
  19. 19. Emam SJ, Badri S, Bayat A, Dashtebozorg N, Khosravi A. Evaluation of 278 HLA-B27 positive patients suspected of seronegative spondyloarthropathies. Pakistan J Med Sci. 2007; 23(5): 728-732.
    Search in Google Scholar
  20. 20. McMichael A, Bowness P. HLA-B27:natural function and pathogenic role in spondyloarthritis. Arthritis Res. 2002; 4(Suppl 3): S153-S158.
    Open DOISearch in Google Scholar
  21. 21. Sahin S, Aydogan L, Benli I, Ozyurt H. Distribution of HLA-B27 and CYP2D6*4 mutations in the middle Black Sea area (Tokat) of Turkey. Genet Molec Res. 2011; 10(4): 3987-3991.
    Open DOISearch in Google Scholar
  22. 22. Sheehan NJ. The ramifications of HLA-B27. J Roy Soc Med. 2004; 97(1): 10-14.
    Open DOISearch in Google Scholar
  23. 23. Dhurandhar PS, Shankarkumar U. HLA Association in seronegative spondyloarthritis patients from Mumbai, India. Int J Hum Genet. 2007; 7(3): 235-239.
    Open DOISearch in Google Scholar
  24. 24. Pitchappan RM, Balakrlshnan K, Mahendran V, Brahmajathi V. HLA and disease susceptibility in Tamil Nadu, S. India. Indian J Hum Genet. 1995; 1(1):56-62.
    Search in Google Scholar
  25. 25. Kim T-H, Uhm W-S, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol. 2005; 17(4): 400-405.
    Open DOISearch in Google Scholar
  26. 26. Colmegna I, Cuchacovich R, Espinoza LR. HLA- B27 associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004; 17(2): 348-369.
    Open DOISearch in Google Scholar
  27. 27. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheumatic Dis Clin North Am. 2009; 35(1): 21-44.
    Open DOISearch in Google Scholar
  28. 28. FitzGerald O, Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther. 2009; 11(1): 214-223.
    Open DOISearch in Google Scholar
  29. 29. Khairallah M,Yahia SB, Ladjimi A, Messaoud R, Zaouali S, Attia S,Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye. 2007; 21(1): 33-39.
    Open DOISearch in Google Scholar
  30. 30. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27: what’s new? In: Pleyer U, Forrester JV, Eds. Uveitis and Immunological Disorders. Heidelberg: Springer- Verlag. 2009:9-17.
    Open DOISearch in Google Scholar
  31. 31. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Survey Ophtalmol. 2005; 50(4): 364-388.
    Open DOISearch in Google Scholar
  32. 32. Mishra MN, Bharucha KM. HLA-B27 Association with uveitis in an Asian Indian population. Iranian J Immunol. 2011; 8(2): 85-89.
    Search in Google Scholar
DOI: https://doi.org/10.2478/bjmg-2013-0007 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 55 - 60
Published on: Apr 2, 2013
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Ankylosing spondylitis (AS),
Cytotoxic T cells (CTL),
Heavy chain (HC),
Human leukocyte antigen(s) (HLAs),
Major histocompatibility complex (MCH),
Relative risk (RR),
Spondyarthropathies (SpA),
T cell receptors (TCR)
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2013 S. Vojvodić, D. Ademović-Sazdanić, I. Busarčević, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 15 (2012): Issue 2 (December 2012)
Previous article
Next article